Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten G Rasch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Cell Biology|September 9, 2010
Dynamic interplay between the collagen scaffold and tumor evolutionMikala Egeblad, Morten G Rasch, Valerie M Weaver
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Intact and cleaved uPAR forms: diagnostic and prognostic value in cancerMorten G Rasch, Ida K Lund, Charlotte E Almasi, et al.
Journal of Immunological Methods|September 2, 2008
Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodiesMorten G Rasch, Jesper Pass, Martin Illemann, et al.
Protein Expression and Purification|March 11, 2010
Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cellsMorten G Rasch, Ida K Lund, Martin Illemann, et al.
Clinical Chemistry|August 31, 2010
A new assay for measurement of the liberated domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancerTine Thurison, Anne F Lomholt, Morten G Rasch, et al.
Frontiers in Pharmacology|July 4, 2012
Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivoIda K Lund, Morten G Rasch, Signe Ingvarsen, et al.
Glycoconjugate Journal|August 11, 2012
Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicityKirstine Lavrsen, Caroline B Madsen, Morten G Rasch, et al.
The Journal of Biological Chemistry|September 19, 2008
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivoIda K Lund, Annika Jögi, Birgitte Rønø, et al.
Thrombosis and Haemostasis|June 6, 2007
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivoJesper Pass, Annika Jögi, Ida K Lund, et al.
Cancer Cell|April 21, 2012
Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistanceElizabeth S Nakasone, Hanne A Askautrud, Tim Kees, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Cell Biology|September 9, 2010
Dynamic interplay between the collagen scaffold and tumor evolutionMikala Egeblad, Morten G Rasch, Valerie M Weaver
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Intact and cleaved uPAR forms: diagnostic and prognostic value in cancerMorten G Rasch, Ida K Lund, Charlotte E Almasi, et al.
Journal of Immunological Methods|September 2, 2008
Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodiesMorten G Rasch, Jesper Pass, Martin Illemann, et al.
Protein Expression and Purification|March 11, 2010
Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cellsMorten G Rasch, Ida K Lund, Martin Illemann, et al.
Clinical Chemistry|August 31, 2010
A new assay for measurement of the liberated domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancerTine Thurison, Anne F Lomholt, Morten G Rasch, et al.
Frontiers in Pharmacology|July 4, 2012
Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivoIda K Lund, Morten G Rasch, Signe Ingvarsen, et al.
Glycoconjugate Journal|August 11, 2012
Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicityKirstine Lavrsen, Caroline B Madsen, Morten G Rasch, et al.
The Journal of Biological Chemistry|September 19, 2008
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivoIda K Lund, Annika Jögi, Birgitte Rønø, et al.
Thrombosis and Haemostasis|June 6, 2007
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivoJesper Pass, Annika Jögi, Ida K Lund, et al.
Cancer Cell|April 21, 2012
Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistanceElizabeth S Nakasone, Hanne A Askautrud, Tim Kees, et al.
Pageof 2